Around the Practice

Preet M. Chaudhary, MD, and his medical team join Hector Cuevas,a patient with graft-vs-host disease, to discuss graft-vs-host disease (GVHD) and their treatment experiences.

A panel of experts review the historically available treatment decision-making tools for patients with colorectal cancer and discuss the current and future use of minimal residual disease (MRD) and circulating tumor DNA (ctDNA) testing as it relates to key clinical trial data.

Centering discussion on several patient cases, expert panelists review key updates in the use of bispecific antibodies to manage multiple myeloma.

In review of recent clinical data, expert panelists highlight novel therapeutic approaches in the setting of newly diagnosed and relapsed multiple myeloma.

A panel of experts discusses recent advances and key clinical trial data presented at ASH 2022 concerning the treatment of multiple myeloma.

A panel of experts discusses key updates in the treatment of chronic lymphocytic leukemia presented at ASH 2022, and how it can be applied to clinical practice.

A panel of experts from the Moffit Cancer Center share updates in the multiple myeloma treatment landscape, highlighting recent clinical data and aspects of their own experience.

A panel of experts joins Anne-Marie Jacob, a patient with multiple myeloma, to discuss the treatment of multiple myeloma with bispecifics and their personal experiences with the agents.

Expert panelists review data presented at recent conferences and discuss current strategies utilized in the management of HR+ metastatic breast cancer.

Experts from the Cleveland Clinic provide an overview of recent updates in the treatment landscape for patients with multiple myeloma, discussing patient cases, clinical trials, and improving outcomes for patients.

Centering discussion on several patient cases, expert oncologists work together to review the evolving treatment landscape of HER2+ breast cancer with a focus on brain metastases.

A panel of esteemed breast cancer experts discuss the latest research in the treatment of HER2+ metastatic breast cancer with brain metastases and how data updates would affect treatment-decision making in three patient cases.

A panel of expert oncologists reviews key updates from recent meetings regarding the testing and treatment of metastatic colorectal cancer in the context of real-world clinical practice.

Elle Charnisky, a patient with stage IV HER2+ metastatic colorectal cancer (mCRC), joins a panel of healthcare professionals to discuss how HER2 alternations are detected and how patients with HER2+ mCRC are optimally treated to improve outcomes.

Centering discussion on several patient cases, expert oncologists review key data updates in the multiple myeloma treatment landscape from IMS 2022 and other recent meetings.

A panel of experts reviews key data updates in multiple myeloma from IMS [International Myeloma Society Annual Meeting] 2022 and other recent meetings and discusses how they can be best applied in clinical practice.

Centering discussion around three patient cases of multiple myeloma, expert oncologists from the University of Pennsylvania review the optimal selection and application of treatment.

A panel of experts discusses the treatment approaches to three clinical cases of multiple myeloma in the context of data presented at recent meetings and reviews how it can be applied to daily clinical practice.

Centering discussion on clinical scenarios of urothelial carcinoma, expert oncologists review recent data and discuss how patient care is evolving.

A panel of experts in multiple myeloma discusses recent data updates from IMS 2022 [International Myeloma Society Annual Meeting] and how it influences treatment strategies in clinical practice.

Drs Andre Goy, Lori Leslie, and Andrew Ip, expert lymphoma physicians from the John Theurer Cancer Center at Hackensack University Medical Center, discuss recent updates on the role of CAR T-cell therapy in lymphoma treatment.

Centering discussion on two clinical scenarios, expert panelists review recent evolutions in the field of graft vs host disease management and provide their perspective on optimal treatment strategies.

Expert oncologists review key studies in the m CSPC treatment landscape and discuss how evidence can be applied to clinical practice to improve patient outcomes.

Centering discussion on patient scenarios, expert oncologists define the current and future use of MRD and ctDNA in both colorectal and breast cancer management.

A panel of experts in breast oncology builds a lively discussion on evolving approaches in the management of HER2+ metastatic breast cancer, including key considerations for the treatment of patients with brain metastases.

A panel of oncologists discuss recent updates in the management of patients with myelofibrosis and share insight into their strategies for two case scenarios.

A panel of experts review real-world clinical scenarios to highlight recent advances in the management of multiple myeloma.

Expert panelists review key data from recent meetings on the management of multiple myeloma and consider how these can be applied to clinical practice.

A panel of experts review two patient cases to elucidate data in the adjuvant setting of non–small cell lung cancer.

A panel of experts from Emory University review several key data updates in multiple myeloma from recent meetings and discuss how the data can be applied to clinical practice to improve patient outcomes.